Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2026-01-02 | 2026-01-12 | 275154 |
| APO-SIMVASTATIN | 80MG | TABLET | Resolved | 2020-01-15 | 2020-04-09 | 103391 |
| APO-SIMVASTATIN | 20MG | TABLET | Resolved | 2021-07-23 | 2022-03-01 | 142985 |
| APO-SIMVASTATIN | 20MG | TABLET | Resolved | 2019-04-04 | 2019-04-15 | 80545 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2021-10-01 | 2021-10-20 | 146519 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2021-10-01 | 2021-10-25 | 146522 |
| APO-SITAGLIPTIN MALATE | 25MG | TABLET | Resolved | 2024-04-12 | 2024-05-31 | 224977 |
| APO-SITAGLIPTIN MALATE | 100MG | TABLET | Actual shortage | 2025-08-14 | 2025-12-11 | 265266 |
| APO-SITAGLIPTIN MALATE | 25MG | TABLET | Resolved | 2024-05-10 | 2024-05-31 | 227717 |
| APO-SITAGLIPTIN MALATE | 25MG | TABLET | Actual shortage | 2025-10-16 | 2025-12-11 | 269763 |
| APO-SITAGLIPTIN MALATE | 100MG | TABLET | Resolved | 2023-03-30 | 2023-04-14 | 188411 |
| APO-SITAGLIPTIN MALATE | 25MG | TABLET | Resolved | 2023-02-09 | 2023-04-06 | 184112 |
| APO-SITAGLIPTIN MALATE | 100MG | TABLET | Actual shortage | 2025-10-16 | 2025-12-11 | 269776 |
| APO-SITAGLIPTIN MALATE | 100MG | TABLET | Actual shortage | 2025-10-16 | 2025-12-11 | 269779 |
| APO-SITAGLIPTIN MALATE | 25MG | TABLET | Resolved | 2024-08-29 | 2024-10-04 | 236246 |
| APO-SITAGLIPTIN MALATE | 50MG | TABLET | Resolved | 2024-04-12 | 2024-05-31 | 224996 |
| APO-SITAGLIPTIN MALATE | 25MG | TABLET | Actual shortage | 2025-10-16 | 2025-12-11 | 269773 |
| APO-SITAGLIPTIN MALATE | 50MG | TABLET | Actual shortage | 2025-11-06 | 2025-12-11 | 271257 |
| APO-SITAGLIPTIN MALATE | 50MG | TABLET | Actual shortage | 2025-11-20 | 2025-12-11 | 272338 |
| APO-SITAGLIPTIN MALATE | 50MG | TABLET | Resolved | 2023-03-30 | 2023-05-19 | 188415 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119950 |
| APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
| APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |